Vimarsana
Biggest News Aggregation in the World

Page 24 - Peter Marks News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Peter Marks. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Peter Marks Today - Breaking & Trending Today

FDA OKs First Cellular Therapy for Melanoma - Vimarsana News

FDA OKs First Cellular Therapy for Melanoma

Lifileucel approved as treatment for advanced melanoma after anti-PD-1 and targeted therapy

FDA Approves First Cellular Treatment For Advanced Melanoma - Vimarsana News

FDA Approves First Cellular Treatment For Advanced Melanoma

The FDA approved the first-ever T cell therapy for advanced melanoma.

Source: forbes.com
FDA Approves First Cellular Therapy to Treat Patients with Unresectable or Metastatic Melanoma - Vimarsana News

FDA Approves First Cellular Therapy to Treat Patients with Unresectable or Metastatic Melanoma

The FDA approved Amtagvi, the first cellular therapy for the treatment of adults with unresectable or metastatic melanoma previously treated with a PD-1 blocking antibody, and if BRAF V600 mutation positive, a BRAF inhibitor with or without a MEK inhibitor.

Source: fda.gov
FDA Approves First Cellular Therapy to Treat Patients with Unresectable or Metastatic Melanoma - Vimarsana News

FDA Approves First Cellular Therapy to Treat Patients with Unresectable or Metastatic Melanoma

/PRNewswire/ -- Today, the U.S. Food and Drug Administration approved Amtagvi, the first cellular therapy indicated for the treatment of adult patients with a...

Artswatch : Rubenstein Leaves KenCen; NGA's Cornell Trove; Helen Hayes Nominations - Vimarsana News

Artswatch : Rubenstein Leaves KenCen; NGA's Cornell Trove; Helen Hayes Nominations

Rubenstein to Conclude Kennedy Center Chairmanship